J Korean Ophthalmol Soc.  2009 Oct;50(10):1569-1575. 10.3341/jkos.2009.50.10.1569.

Effect of Methylglyoxal on the Oxidative Stress in Trabecular Meshwork Cells

Affiliations
  • 1Department of Ophthalmology, Catholic University of Daegu College of Medicine, Daegu, Korea. jwkim@cu.ac.kr

Abstract

PURPOSE
To investigate the effect of methylglyoxal (MG), intermediate metabolite of advanced glycation end products(AGE), on the induction of oxidative stress in human trabecular meshwork cells (HTMC).
METHODS
Primarily cultured HTMC were exposed to at concentrations of 0, 30, 100, and 300 micrometer of MG for 18 hours, with or without co-exposure to N-acetyl-cysteine. Cellular survival and apoptosis were assessed by MTT assay and flow cytometry using annexin-PI double staining. Production of nitric oxide (NO), superoxide, and reactive oxygen species (ROS) was assessed by Griess assay, cytochrome c assay, and dichlorofluorescein diacetate assay, respectively.
RESULTS
MG did not affect cellular survival at concentrations under 100 micrometer, but induced apoptosis of HTMC at concentrations over 100 micrometer. MG decreased NO production, accompanied with increased superoxide production. In addition, MG increased ROS, which were abolished by N-acetylcysteine.
CONCLUSIONS
MG induced oxidative stress by decreasing NO production, accompanied by increasing superoxide and ROS productions in HTMC. AGE could induce trabecular meshwork dysfunction.

Keyword

Advanced glycation end products; Methylglyoxal; Oxidative stress; Trabecular meshwork cells

MeSH Terms

Acetylcysteine
Apoptosis
Cytochromes c
Flow Cytometry
Glycosylation End Products, Advanced
Humans
Nitric Oxide
Oxidative Stress
Pyruvaldehyde
Reactive Oxygen Species
Superoxides
Trabecular Meshwork
Acetylcysteine
Cytochromes c
Glycosylation End Products, Advanced
Nitric Oxide
Pyruvaldehyde
Reactive Oxygen Species
Superoxides
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr